Wayne State University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wayne State University sits in the top decile of US sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count).
Wayne State University: 163 sponsored US clinical trials, 22 recruiting.
Wayne State University sponsors 163 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 115 completed. 13 of these trials are in Phase 3-4 (later-stage) and 30 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 4 trials.
Top-decile sponsor footprint
Wayne State University ranks in the top decile of sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
115 of 125 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
163 total, page 2 of 4
Effects of Delta9-tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R33 Study
NCT04080427
Virtual Human Technology for Patients With Chronic Pain
NCT04349033
Lower Limb Compression Prevents Hypotension After Epidural in Labor
NCT04750486
Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder
NCT04262193
Feasibility and Efficacy of a Brief Mindfulness-Based Intervention SMOKING INTERVENTION VIA THE INTERNET
NCT04572126
Improving Diabetes in Emerging Adulthood
NCT04066959
Improving Outcomes for Patients With SDB and Insufficient Sleep
NCT04279834
The Parenting Young Children Check-up Evaluation
NCT04628546
Adductor Canal Blocks With Bupivacaine and Magnesium After Same-day Discharge Total Knee Arthroplasty Improve Post-operative Pain Relief and Decrease Opioid Consumption: a Prospective Randomized Controlled Trial
NCT05004636
Breast Milk vs Sucrose in Relieving Procedural Pain in Preterm Neonates During Blood Draw by Automated Heel Lance
NCT04898881
The Parenting Young Children Check-up: Proof-of-Concept Trial
NCT04113304
Supporting Habit Formation to Attenuate Prefrailty in Elders: Pilot Study
NCT04140890
The Facing Pain Study
NCT04010019
Steroid Sensitive Nephrotic Syndrome in Children
NCT03878914
Student Anxiety & Stress Study
NCT03986125
Non-Invasive Jugular Venous Blood Volume Assessment (BVI)
NCT04208438
Protective Genetic Factors Against Neurological Diseases
NCT03914599
Investigating the Wrinkle Reduction Potential of a Novel Compounded Skin Care Cream
NCT03878381
Bringing Exposure Therapy to Real-Life Context With Augmented Reality
NCT03649347
The Heroes Circle Opioid Project
NCT03595007
Sleep and Breathing in the General Population - Chemical Stimuli
NCT04720547
Frailty Prevention Program to Prevent Frailty Among Older African Americans
NCT03585972
Mobile Phone Application Versus Handheld Device for Fetal Vibroacoustic Stimulation
NCT03446248
Translating an Efficacious Illness Management Intervention for Youth With Asthma
NCT03317977
University of Michigan / Wayne State Chronic Pain Study
NCT03391661
Effects of Stress and Drug-cue Exposure (SCM)
NCT03154567
Arab American Women's Health Study
NCT03303326
Effectiveness Trial of an E-Health Intervention To Support Diabetes Care in Minority Youth (3Ms)
NCT03168867
Arts and Movement Therapies for Trauma
NCT03515564
Palm Tocotrienols in Chronic Hemodialysis (USA)
NCT02358967
Telephone-Delivered Exercise for Multiple Sclerosis Fatigue
NCT03256851
Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study
NCT03008005
Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser
NCT03054155
Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users
NCT03154580
An Algorithmic Approach to Ventilator Withdrawal at the End of Life
NCT03121391
Molecular Mechanisms of Antipsychotic-induced Insulin Resistance
NCT02708394
Brief Alcohol E-Interventions Study
NCT02952872
Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence
NCT03015246
Back School for Non-specific Low Back Pain (LBP) in an Urban Setting
NCT02990585
Study to Understand Pain Experiences in Relationships
NCT02859545
Motivational Enhancement System for Adherence (MESA) for Youth Starting ART
NCT02761746
Investigation of Nicotine Seeking Behavior in Current Smokers
NCT03670212
Effects of Cannabidiol on Marijuana-seeking in Humans
NCT02777502
The Tailored-Motivational Interviewing Project
NCT03181022
Pharmacoepigenetics of Bipolar Disorder Treatment
NCT02374996
Feasibility Testing of a Hospice Family Caregiver Intervention to Improve Patient Dyspnea Care
NCT02441868
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
NCT02191605
Reducing Stress in Adolescents and Young Adults With Type 1 Diabetes to Improve Diabetes Care
NCT02760303
Early Versus Late Caffeine for ELBW Newborns
NCT02524249
Exparel for Postoperative Pain Management in Shoulder Surgery
NCT02472314
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 18 |
| Phase 2 | 12 |
| Phase 3 | 2 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the Wayne State University pipeline
22 recruiting of 163 indexed (13% open); 115 completed (71%).
Phase mix: 13 late (III/IV) vs 30 early (I/II) (early-phase heavy).
Top condition: Hypertension (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wayne State University: open-pipeline peers nationwide
Peers matched on 163 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Wayne State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 163 trials (± recruiting share)
- Temple University · 163 trials · 13% recruiting
- Tufts University · 163 trials · 6% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
- University of Vermont · 162 trials · 9% recruiting
Sponsors near 13% open enrollment (± trial volume)
- University of Michigan · 13% recruiting · 1,327 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Beth Israel Deaconess Medical Center · 14% recruiting · 488 trials
- Albany Medical College · 13% recruiting · 52 trials
Related
What to do with this Wayne State University page
163 registered trials is a research-attention snapshot, not an endorsement of Wayne State University or any single study.
- 22 of Wayne State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Wayne State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Wayne State University pipeline card: 163 registered trials from official public datasets.Report a data error.